Judge Questions Validity Of Cephalon's Epilepsy Drug Patent
A New Jersey federal judge on Thursday declined to block sales of Sun Pharmaceutical Industries Ltd.'s generic version of Cephalon Inc.'s anti-epilepsy drug, saying Cephalon had failed to prove infringement and...To view the full article, register now.
Already a subscriber? Click here to view full article